Physician profile
Mitchell Berger
NPI 1053362970
$6,945.31
in general payments reported to CMS, 2019-2025
34 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,414 · 2020: $396 · 2021: $330 · 2022: $436 · 2023: $556 · 2024: $665 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.83 |
| Education | $469.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $3,756.00 | 2019 | |
| Janssen Biotech, INC. | $737.96 | 2019-2025 | Erleada, Tecvayli, Darzalex |
| Astellas Pharma US INC | $582.77 | 2019-2025 | Xtandi, Vyloy |
| Pfizer INC. | $369.12 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $229.46 | 2019-2023 | Opdivo |
| Sumitomo Pharma America, INC. | $134.12 | 2023-2025 | Orgovyx |
| Pharmacyclics LLC, An Abbvie Company | $97.84 | 2019-2022 | |
| Myovant Sciences INC. | $89.26 | 2022 | |
| Exact Sciences Corporation | $69.40 | 2023-2024 | Cologuard Collection Kit |
| Celgene Corporation | $67.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.44 | 2022-2023 | |
| Lilly USA, LLC | $62.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $50.25 | 2019-2024 | Tagrisso |
| Sanofi Pasteur INC. | $49.76 | 2024 | |
| Karyopharm Therapeutics INC. | $48.05 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $45.95 | 2019 | |
| Array Biopharma INC | $45.22 | 2024 | Mektovi, Xalkori, Lorbrena |
| Amgen INC. | $45.13 | 2022-2023 | Xgeva, Vectibix, Nplate |
| Inspire Medical Systems, INC. | $43.65 | 2025 | Inspire |
| Mylan Institutional INC. | $41.32 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $30.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.68 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.40 | 2020 | |
| Eisai INC. | $25.76 | 2025 | |
| Beigene USA, INC. | $24.43 | 2022 | |
| Glaxosmithkline, LLC. | $23.87 | 2020 | |
| Genentech USA, INC. | $23.75 | 2019 | |
| Novocure INC. | $23.48 | 2024 | Optune Lua (Novottf-200t) |
| Spectrum Pharmaceuticals INC. | $21.02 | 2023 | Rolvedon |
| Emd Serono, INC. | $20.74 | 2019 | |
| Echosens North America, INC. | $18.91 | 2025 | Fibroscan |
| Janssen Pharmaceuticals, INC | $18.74 | 2020 | |
| Menarini Silicon Biosystems, INC. | $17.02 | 2023 | Cellsearch |
| Aurobindo Pharma USA, INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.